At least 18 more people have fallen prey to COVID-19 in Khyber Pakhtunkhwa on Saturday, bringing the coronavirus death toll in the province to 1020.
The Phase 1 and 2 clinical trials of the CanSino’s vaccine candidate showed it has the potential to prevent diseases caused by the coronavirus
WHO recently named AstraZeneca's AZD1222 and Moderna's mRNA-1273 as two of the leading candidates in the COVID-19 vaccine race
The novel coronavirus claimed 68 more lives in the country in the past 24 hours.
“Nearly 5,500 patients in 39 countries have so far been recruited into the Solidarity trial”
Previous trial results had shown that the drug did not help patients with less severe COVID-19, the disease caused by the novel coronavirus
Trump also expressed optimism that the United States would soon come up with a workable vaccine for the novel coronavirus
Shares of Moderna fell 7% on Thursday after medical news site STAT reported a delay in a large trial testing the biotech’s potential coronavirus vaccine
Studies have shown that the anti-viral drug can reduce the duration of hospital stays for those suffering from the novel coronavirus
The daily U.S. tally stood at 55,274 late Thursday